In this issue:
Adolescent hypertension increases future risk of ESKD
Urinary oxalate excretion and CKD progression
High incidence of ESKD in Fiji
Veverimer reduces metabolic acidosis in patients with CKD
Glecaprevir/pibrentasvir in patients with severe renal impairment
New-onset type 2 diabetes in patients with CKD
Molidustat treatment for anaemia in CKD
Tenapanor decreases hyperphosphataemia in haemodialysis patients
Improving CKD-specific measures of HR-QOL
Please login below to download this issue (PDF)